NCT07519837 2026-04-09
PRCC-MO
China Medical University, China
Phase NA Recruiting
Clinical Trials
12 trialsNCT06989437 2026-04-08
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Pfizer
Phase 2/3 Recruiting
NCT07112196 2026-03-30
VINCIT
CatalYm GmbH
Phase 2/3 Recruiting
NCT05705492 2026-01-21
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT04067167 2026-01-20
FREEDOM
University of Erlangen-Nürnberg Medical School
Phase NA Recruiting
NCT07338487 2026-01-14
A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Second Xiangya Hospital of Central South University
Phase 1 Recruiting
NCT05865535 2026-01-08
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
AVEO Pharmaceuticals, Inc.
Phase 1 Recruiting
NCT06937177 2025-12-12
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy
Endevica Bio
Phase 2 Recruiting
NCT06898255 2025-06-05
A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
Genfleet Therapeutics (Shanghai) Inc.
Phase 1 Recruiting
NCT06517199 2024-07-24
Olanzapine for Cancer Related Anorexia-cachexia Syndrome
Mahidol University
Phase 3 Recruiting
NCT04627376 2022-09-02
Multimodal Program for Cancer Related Cachexia Prevention
Cyprus University of Technology
Phase NA Recruiting
NCT05307367 2022-05-16
PANACEA
University of Copenhagen
Phase NA Recruiting